Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Nov;111(11):2137-43.
doi: 10.1016/j.ophtha.2004.05.027.

Contact transscleral neodymium:yttrium-aluminum-garnet laser cyclophotocoagulation Long-term outcome

Patty Lin  1 , Gadi Wollstein, Ioannis P Glavas, Joel S Schuman
Affiliations

Contact transscleral neodymium:yttrium-aluminum-garnet laser cyclophotocoagulation Long-term outcome

Patty Lin et al. Ophthalmology. 2004 Nov.

Erratum in

  • Ophthalmology. 2005 Mar;112(3):446

Abstract

Purpose: Contact transscleral neodymium:yttrium-aluminum-garnet (Nd:YAG) laser cyclophotocoagulation (CYC) is a treatment option for advanced glaucoma refractory to alternative treatments. This study determined the long-term efficacy and risks of contact transscleral Nd:YAG laser CYC.

Design: A prospective study was performed with patients with advanced, uncontrolled glaucoma who received CYC from 1988 through 1989.

Participants: Records for 68 eyes of 64 patients were obtained and reviewed for the 10-year follow-up.

Methods: A transscleral continuous-wave Nd:YAG laser was used for photocoagulation of the ciliary body.

Main outcome measures: Intraocular pressure (IOP), visual acuity, and second intervention. Failure was defined as the need for second intervention, IOP of more than 25 mmHg, or IOP of less than 3 mmHg.

Results: The mean follow-up period was 5.85+/-4.0 years (range, 0.1-10 years). The mean preoperative IOP of 36.3+/-10.1 mmHg decreased to 22.6+/-11.3 mmHg at 1 year of follow-up (P<0.001). The mean postoperative IOP at 5 years was 21.8+/-13.3 mmHg (P<0.001) and was 18.9+/-12.2 mmHg at 10 years of follow-up (P<0.001). A second intervention after CYC was required in 30 eyes (44.1%). Six eyes (8.8%) with initial visual acuity of counting fingers or worse progressed to no light perception, and 5 of 8 eyes (62.5%) with visual acuity better than 20/200 lost 2 or more Snellen lines. Hypotony developed in 3 eyes (4.4%). Overall, the failure rate by 10 years of follow-up was 51.5% (35/68 eyes).

Conclusions: Cyclophotocoagulation resulted in a significant reduction of IOP after surgery at 1, 5, and 10 years of follow-up; however, 51.5% of eyes failed by the end of 10 years, with most failures occurring within the first year (40%). Although CYC provides a useful method to lower IOP significantly, this study suggests that its success in controlling IOP is tempered by its failure rate and risk of complications, including visual loss, phthisis, and loss of light perception.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Scatterplot of pretreatment intraocular pressure (IOP) versus final visit IOP. Solid lines represent the linear regression for the mean and the 95% confidence intervals.
Figure 2
Figure 2
Mean (standard error) intraocular pressure (IOP) measurements after contact transscleral continuous wave neodymium:yttrium–aluminum–garnet laser cyclophotocoagulation over the 10-year follow-up period.
Figure 3
Figure 3
Scatterplot of pretreatment visual acuity (VA) versus final postoperative visit VA. Some points overlie others and may represent more than one patient. CF = counting fingers; HM = hand movements; LP = light perception; NLP = no LP.
Figure 4
Figure 4
Kaplan-Meier survival curve for contact transscleral neodymium:yttrium–aluminum–garnet laser cyclophotocoagulation. Failure was defined as the need for a second intervention, intraocular pressure (IOP) > 25 mmHg or IOP < 3 mmHg.
See this image and copyright information in PMC

Comment in

References

    1. Schuman JS, Puliafito CA, Allingham RR, et al. Contact transscleral continuous wave neodymium:YAG laser cyclophotocoagulation. Ophthalmology. 1990;97:571–80. - PubMed
    1. Schuman JS, Bellows AR, Shingleton BJ, et al. Contact transscleral Nd:YAG laser cyclophotocoagulation: midterm results. Ophthalmology. 1992;99:1089–94. - PubMed
    1. Dickens CJ, Nguyen N, Mora JS, et al. Long-term results of noncontact transscleral neodymium:YAG cyclophotocoagulation. Ophthalmology. 1995;102:1777–81. - PubMed
    1. Shields MB, Shields SE. Noncontact transscleral Nd:YAG cyclophotocoagulation: a long-term follow-up of 500 patients. Trans Am Ophthalmol Soc. 1994;92:271–83. - PMC - PubMed
    1. Maus M, Katz LJ. Choroidal detachment, flat anterior chamber, and hypotony as complications of neodymium:YAG laser cyclophotocoagulation. Ophthalmology. 1990;97:69–72. - PubMed

Publication types